Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study

Prostate Cancer and Prostatic Diseases volume 8, pages 215–218 (2005)Cite this article

Abstract

In the present study we aimed to demonstrate the efficacy of short-term pretreatment with finasteride in patients undergoing transurethral resection of the prostate (TUR-P). For this purpose 40 patients with BPH, who were candidates for TUR-P, were randomized into two groups. The first group (n=20) received 5 mg finasteride/day for 4 weeks prior to surgery and the second group (n=20) remained as the control. Patients who underwent prior prostate or urethral surgery and had a diagnosis of prostate cancer or chronic renal failure, patients who received finasteride, aspirin, coumadin or similar anticoagulant drugs prior to surgery and patients who had capsule perforations or open sinuses during the surgery were excluded from the study. All patients had a normal digital rectal examination and PSA values less than 4 ng/ml. As we look at the results there was no statistically significant difference between the finasteride group and control group regarding age, IPSS, PSA, prostate volumes, preoperative serum hemoglobin, hematocrit values and mean operating times and used irrigating fluids. The total amount of bleeding and bleeding per gram resected tissue were significantly lower in the finasteride group regardless of prostate volume. Furthermore the decrease in the hemoglobin and hematocrit values was higher in the control group. As a conclusion four weeks of finasteride pretreatment provided a significant decrease in peroperative bleeding regardless of prostate volume without any major side effects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC . Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluation of 3885 patients. J Urol 1989; 141: 243–247.

    Article  CAS  PubMed  Google Scholar 

  2. Melchior J, Valk WL, Foret JD, Mebust WK . Transurethral prostatectomy: computerized analysis of 2223 consecutive cases. J Urol 1974; 112: 634–642.

    Article  CAS  PubMed  Google Scholar 

  3. Lissbrant IF, Haggstrom S, Damber JE, Bergh A . Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 1998; 139: 451–456.

    Article  Google Scholar 

  4. Lekas E et al. Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration. Urol Res 1997; 25: 309–314.

    Article  CAS  PubMed  Google Scholar 

  5. Shabsigh A et al. Rapid reduction in blood flow to the rat ventral prostate after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival. Prostate 1998; 36: 201–216.

    Article  CAS  PubMed  Google Scholar 

  6. Carlin BI, Bodner DR, Spinnak JP, Resnick MI . Role of finasteride in the treatment of hematuria secondary to benign prostatic hyperplasia. Prostate 1997; 31: 180–182.

    Article  CAS  PubMed  Google Scholar 

  7. Puchner PJ, Miller MI . The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report. J Urol 1995; 154: 1779–1782.

    Article  CAS  PubMed  Google Scholar 

  8. Sieber PR et al. The treatment of gross hematuria secondary to prostatic bleeding with finasteride. J Urol 1998; 159: 1232–1233.

    Article  CAS  PubMed  Google Scholar 

  9. Joseph IB, Nelson JB, Denmeade SR, Isaacs JT . Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res 1997; 3: 2507–2511.

    CAS  PubMed  Google Scholar 

  10. Haggstrom S, Lissbrant IF, Bergh A, Damber JE . Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J Urol 1999; 161: 1620–1625.

    Article  CAS  PubMed  Google Scholar 

  11. Bailey DM, Foley SJ . Microvascular anatomy in patients with recurrent hematuria related to prostatic hypertrophy (BPH). J Urol 1999; 161: 865 (abstract).

    Article  Google Scholar 

  12. Levine AC et al. Androgens induce the expression of the vascular endothelial growth factors in human fetal prostatic fibroblasts. Endocrinology 1998; 139: 4672–4678.

    Article  CAS  PubMed  Google Scholar 

  13. Kashif KM, Foley SJ, Basketter V, Holmes SA . Haematuria associated with BPH-Natural history and a new treatment option. Prostate Cancer Prostatic Dis 1998; 1: 154–156.

    Article  CAS  PubMed  Google Scholar 

  14. Ekengren J, Hahn RG . Blood loss during transurethral resection of the prostate as measured by the hemocue photometer. Scand J Urol 1993; 27: 501–517.

    Article  CAS  Google Scholar 

  15. Gormley GJ et al. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Eng J Med 1992; 327: 1185–1191.

    Article  CAS  Google Scholar 

  16. Stoner E . The clinical effects of 5α-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group. J Urol 1992; 147: 1298–1302.

    Article  CAS  PubMed  Google Scholar 

  17. Saez C et al. Expression of basic fibroblast growth factors and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride. Prostate 1999; 40: 83–88.

    Article  CAS  PubMed  Google Scholar 

  18. Monti S et al. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by the treatment with finasteride or flutamide. J Androl 1997; 18: 488–494.

    CAS  PubMed  Google Scholar 

  19. Schwartz Jr S et al. Androgen-independent basal cell re-epithelialization, c-erbB-2 mRNA expression and androgen-dependant EGFr mRNA expression in benign prostatic hyperplasia explant cultures treated with finasteride. Int J Cancer 1998; 76: 519–522.

    Article  CAS  PubMed  Google Scholar 

  20. Moon S-Y, Moon W-C, Choi HR, Gi Y-J . Finasteride inhibits angiogenesis and expression of VEGF in human BPH. J Urol 1998; 159: 332 (abstract).

    Google Scholar 

  21. Bailey DM, Foley SJ, Wedderburn A . effect of finasteride on microvessel density (MVD) in patients with recurrent haematuria related to prostatic hypertrophy (BPH). J Urol (suppl) 1999; (abstract).

  22. Hagerty JA, Ginsberg PC, Harmon JD, Harkaway RC . Pretreatment with finasteride decreases perioperative bleeding associated with transurethral resection of the prostate. Urology 2000; 55: 684–689.

    Article  CAS  PubMed  Google Scholar 

  23. Sandfeldt L, Bailey DM, Hahn RG . Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride. Urology 2001; 58: 972–976.

    Article  CAS  PubMed  Google Scholar 

  24. Donohue JF et al. Transurethral resection and bleeding: a randomized, placebo controlled trial of the role of finasteride for decreasing operative blood loss. J Urol 2002; 168: 2024–2026.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Ankara Numune Education and Research Hospital, Ankara, Turkey

    Ö L Özdal, C Özden, K Benli, S Gökkaya, S Bulut & A Memiş

Authors
  1. Ö L Özdal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Özden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Benli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Gökkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Bulut
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Memiş
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ö L Özdal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Özdal, Ö., Özden, C., Benli, K. et al. Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study. Prostate Cancer Prostatic Dis 8, 215–218 (2005). https://doi.org/10.1038/sj.pcan.4500818

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500818

Keywords

This article is cited by

Search

Advanced search

Quick links